Position in INCY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$148,519,056
+$30,573,709 QoQ
Shares Held
1,310,154
+4.5% QoQ
Ownership
0.656%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#29
of 849 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. INCY ranks #2 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
This page
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in INCY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $148,519,056 | 1,310,154 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $117,945,347 | 1,253,138 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $105,929,935 | 1,072,491 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,360,352 | 16,040 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $82,484,830 | 1,211,231 | Shares | Other | 2025-08-13 | |
| 2024-12-31 | $40,455,541 | 585,718 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $84,496,291 | 1,278,310 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $2,033,316 | 33,542 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $16,618,205 | 291,701 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $2,678,558 | 42,659 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $34,056,801 | 589,524 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $9,031,541 | 145,085 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $13,231,914 | 183,090 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $21,430,339 | 266,812 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $3,185,392 | 47,800 | Shares | Other | 2022-11-14 | |
| 2021-12-31 | $30,019,791 | 408,989 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $2,996,331 | 43,564 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,069,628 | 12,714 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,733,165 | 95,154 | Shares | Sole | 2021-05-17 | |
| 2020-03-31 | $4,759 | 65 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||